Listed by the USPTO as YOUTCHOM PENDIE, EMMANUEL LED
Tech Center 1600 • Art Units: 1647
This examiner grants 64% of resolved cases
YOUTCHOM PENDIE, EMMANUEL LED is assigned to Tech Center 1600 and Art Unit 1647. The profile covers 14 resolved cases and reports a 64.3% allowance rate. Interviews are associated with a 41.7% lift in allowance outcomes. The median time to allowance is 1306 days.
The listed companies are Carnegie Mellon University, Hanmi Pharm. Co., Ltd., and Whitehead Institute for Biomedical Research. The listed firms are Jenkins, Taylor & Hunt, P.A., McBee Moore & Vanik, IP, LLC, and MEYER UNKOVIC & SCOTT LLP. The small record limits broad inference, but the interview measure supports purposeful examiner engagement.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17741271 | METHOD FOR BIOMATERIAL FUNCTIONALIZATION WITH IMMOBILIZED EXTRACELLULAR VESICLES | Non-Final OA | Carnegie Mellon University |
| 18041151 | HYPOTENSIVE PHARMACEUTICAL COMPOSITION COMPRISING TRIPLE ACTIVATOR HAVING ACTIVITY FOR ALL OF GLUCAGON, GLP-1, AND GIP RECEPTORS | Non-Final OA | HANMI PHARM. CO., LTD. |
| 18323577 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS | Non-Final OA | Immatics Biotechnologies GmbH |
| 18259277 | GLOBO SERIES ANTIGENS-BINDING CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | Non-Final OA | OBI PHARMA, INC. |
| 17628176 | REMOVAL OF TUMOR CELLS FROM INTRAOPERATIVE AUTOLOGOUS BLOOD SALVAGE BY USING A TRIFUNCTIONAL ANTIBODY | Final Rejection | Lindis Blood Care GmbH |
| 17932057 | CLEAVABLE LINKERS | Non-Final OA | Xilio Development, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy64.3% of resolved applications examined by Emmanuel Led Youtchom Pendie were allowed (14 resolved cases), compared with 39.7% across Art Unit 1647 over the last five years.
This examiner's interview lift is +41.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Emmanuel Led Youtchom Pendie took 1,306 days on average from filing to allowance.
Emmanuel Led Youtchom Pendie examines applications in Art Unit 1647 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
